PT-141 10MG

What is PT-141?

PT-141 (Bremelanotide) — also written PT 141 or PT141 — is a synthetic cyclic peptide from the melanocortin family, studied in research as an agonist at central melanocortin receptors (notably MC4R). In controlled laboratory settings it is used as a reference compound for investigating melanocortin receptor signalling and related neurochemical pathways. Lazarus Labs supplies PT-141 in Australia as a 10 mg lyophilised reference material at ≥ 99 % purity, with a certificate of analysis for every lot. For research use only — not for human or veterinary use.

Research context

PT-141 is an analogue within the melanocortin-agonist class and is studied for its activity at central melanocortin receptors. Laboratories use it as a comparison compound in receptor-binding and neurochemical-signalling research. It is supplied strictly as a reference material for that work.

Specifications

• Presentation: 10 mg per vial
• Purity: ≥ 99 %, confirmed by HPLC and LC-MS
• Form: white lyophilised powder
• Solubility: readily soluble in water (H₂O)
• Manufacturing: GMP-compliant, ISO 9001:2008
• Documentation: third-party certificate of analysis per lot
• Intended use: in-vitro and laboratory research only

Quality & documentation

Every lot of PT-141 is produced in a GMP-compliant, ISO-certified facility and independently verified by a third-party laboratory, with a certificate of analysis reporting HPLC purity and LC-MS identity for your exact batch.

Handling & storage

Store sealed and dry at 2–8 °C. After reconstitution, keep refrigerated and follow your laboratory’s own handling and stability procedures. PT-141 is supplied for research use only and is not for human or veterinary use.

Dispatch & supply in Australia

PT-141 ships from within Australia with tracked delivery, and every order includes the matching certificate of analysis.

Read the citation-backed research overview →

For in-vitro research and laboratory use only · Not for human or animal consumption · Not a therapeutic good · 18+